These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7556968)
41. Decreased levels of salivary prostaglandin E2 and epidermal growth factor in recurrent aphthous stomatitis. Wu-Wang CY; Patel M; Feng J; Milles M; Wang SL Arch Oral Biol; 1995 Dec; 40(12):1093-8. PubMed ID: 8850647 [TBL] [Abstract][Full Text] [Related]
42. Acid sensitization of esophageal mucosal afferents: implication for symptom perception in patients across the gastroesophageal reflux disease spectrum. Szczesniak MM; Fuentealba SE; Cook IJ Clin J Pain; 2013 Jan; 29(1):70-7. PubMed ID: 22330131 [TBL] [Abstract][Full Text] [Related]
43. Saliva and esophageal protection. Kongara KR; Soffer EE Am J Gastroenterol; 1999 Jun; 94(6):1446-52. PubMed ID: 10364005 [TBL] [Abstract][Full Text] [Related]
44. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity? Farré R Neurogastroenterol Motil; 2013 Oct; 25(10):783-99. PubMed ID: 23937353 [TBL] [Abstract][Full Text] [Related]
45. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action. Shafik A; El-Sibai O; Shafik AA; Mostafa R J Gastroenterol Hepatol; 2005 Dec; 20(12):1935-9. PubMed ID: 16336456 [TBL] [Abstract][Full Text] [Related]
46. Saliva transit in patients with gastroesophageal reflux disease. Cassiani RA; Mota GA; Aprile LR; Dantas RO Dis Esophagus; 2015 Oct; 28(7):673-7. PubMed ID: 25082357 [TBL] [Abstract][Full Text] [Related]
47. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Saritas Yuksel E; Hong SK; Strugala V; Slaughter JC; Goutte M; Garrett CG; Dettmar PW; Vaezi MF Laryngoscope; 2012 Jun; 122(6):1312-6. PubMed ID: 22447277 [TBL] [Abstract][Full Text] [Related]
53. Secretion of epidermal growth factor in saliva of duodenal ulcer patients; an association with Helicobacter pylori eradication and erosive esophagitis. Kiluk A; Namiot DB; Namiot Z; Leszczyńska K; Kurylonek AJ; Kemona A Adv Med Sci; 2008; 53(2):305-9. PubMed ID: 18930874 [TBL] [Abstract][Full Text] [Related]
55. Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion. Yamato M; Nagahama K; Kotani T; Kato S; Takeuchi K Digestion; 2005; 72(2-3):109-18. PubMed ID: 16172547 [TBL] [Abstract][Full Text] [Related]
56. Salivary secretion in reflux esophagitis. Sonnenberg A; Steinkamp U; Weise A; Berges W; Wienbeck M; Rohner HG; Peter P Gastroenterology; 1982 Oct; 83(4):889-95. PubMed ID: 7106518 [TBL] [Abstract][Full Text] [Related]
57. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis. Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595 [TBL] [Abstract][Full Text] [Related]
58. The esophageal mucosal resistance: structure and function of an unique gastrointestinal epithelial barrier. Goldstein JL; Watkins JL; Greager JA; Layden TJ J Lab Clin Med; 1994 May; 123(5):653-9. PubMed ID: 8195671 [TBL] [Abstract][Full Text] [Related]
59. Defense mechanism of the esophageal mucosa and esophageal inflammation. Yoshida N; Yoshikawa T J Gastroenterol; 2003 Mar; 38 Suppl 15():31-4. PubMed ID: 12698868 [No Abstract] [Full Text] [Related]
60. Precise role of acid in non-erosive reflux disease. Wang C; Hunt RH Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]